AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA.
Company profile
Ticker
AHROQ
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AtheroNova, Inc., LandBank Group Inc, Trist Holdings, Inc.
SEC CIK
Corporate docs
IRS number
201915083
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
7 Sep 21
8-K
Bankruptcy or Receivership
3 Mar 15
8-K
AtheroNova Receives Additional Notices of Debt Acceleration
19 Feb 15
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
13 Feb 15
8-K
Departure of Directors or Certain Officers
9 Dec 14
8-K
Departure of Directors or Certain Officers
20 Nov 14
10-Q
2014 Q3
Quarterly report
19 Nov 14
NT 10-Q
Notice of late quarterly filing
14 Nov 14
8-K
Entry into a Material Definitive Agreement
31 Oct 14
424B4
Prospectus supplement with pricing info
29 Oct 14
Latest ownership filings
SC 13G/A
AtheroNova Inc.
12 Feb 16
SC 13G/A
AtheroNova Inc.
8 Feb 16
SC 13G/A
AtheroNova Inc.
6 Feb 15
SC 13G
AtheroNova Inc.
30 Jan 15
SC 13G/A
AtheroNova Inc.
12 Jan 15
SC 13G
AtheroNova Inc.
23 Dec 14
SC 13G/A
AtheroNova Inc.
13 Feb 14
SC 13D/A
AtheroNova Inc.
11 Sep 13
SC 13D/A
AtheroNova Inc.
21 Jun 13
SC 13D
EUROPA INTERNATIONAL INC
17 Apr 13
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|